ADDUS HOMECARE CORP (ADUS) Stock News
NASDAQ:ADUS - Nasdaq - US0067391062 - Common Stock - Currency: USD
ADUS Latest News, Press Relases and Analysis
Why ADDUS HOMECARE CORP (NASDAQ:ADUS) qualifies as a quality stock.
A fundamental analysis of (NASDAQ:ADUS): Is NASDAQ:ADUS a Suitable Choice for Quality Investing?
Addus HomeCare to Participate in Upcoming Investor Conferences in May
Addus HomeCare (ADUS) Q1 Earnings: Taking a Look at Key Metrics Versus Estimates
While the top- and bottom-line numbers for Addus HomeCare (ADUS) give a sense of how the business performed in the quarter ended March 2025, it could be worth looking at how some of its key metrics compare to Wall Street estimates and year-ago values.
Addus HomeCare (ADUS) Beats Q1 Earnings Estimates
Addus HomeCare (ADUS) delivered earnings and revenue surprises of 6.77% and 0.68%, respectively, for the quarter ended March 2025. Do the numbers hold clues to what lies ahead for the stock?
Mentions: DVA
Addus HomeCare (NASDAQ:ADUS) Misses Q1 Revenue Estimates
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) missed Wall Street’s revenue expectations in Q1 CY2025, but sales rose 20.3% year on year to $337.7 million. Its non-GAAP profit of $1.42 per share was 6.5% above analysts’ consensus estimates.
Addus HomeCare Announces First Quarter 2025 Financial Results
Addus HomeCare (ADUS) Reports Earnings Tomorrow: What To Expect
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) will be reporting earnings tomorrow after the bell. Here’s what investors should know.
Ally Financial Inc. (ALLY): Among the Cheap Dividend Stocks Being Targeted by Short Sellers
We recently published a list of the 25 Cheap Dividend Stocks Being Targeted by Short Sellers. In this article, we are going to take a look at where Ally Financial Inc. (NYSE:ALLY) stands against other cheap dividend stocks. Short sellers — investors who profit from falling stock prices —are seeing a surge in success in 2025. […]
Earnings Preview: Elanco Animal Health Incorporated (ELAN) Q1 Earnings Expected to Decline
Elanco Animal Health (ELAN) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Mentions: ELAN
Can Humana Beat Q1 Earnings Estimates on Growing Premiums?
HUM's first-quarter results are likely to benefit from higher Medicare stand-alone PDP revenues.
ADUS or USPH: Which Is the Better Value Stock Right Now?
ADUS vs. USPH: Which Stock Is the Better Value Option?
Mentions: USPH
Addus HomeCare (ADUS) Earnings Expected to Grow: Should You Buy?
Addus HomeCare (ADUS) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Molina Healthcare Q1 Earnings Beat Estimates on Growing Premiums
MOH continues to expect 2025 premium revenues to be around $42 billion.
Addus HomeCare Announces First Quarter 2025 Earnings Release and Conference Call
CYH to Sell Stake in Cedar Park Regional to Ascension in $460M Deal
Community Health is set to divest an 80% ownership stake in Cedar Park Regional to Ascension Health.
Addus HomeCare Announces Planned Retirement of Brad Bickham
Addus HomeCare to Participate in March Investor Conferences
Addus HomeCare to Participate in TD Cowen 45th Annual Health Care Conference
Addus HomeCare (NASDAQ:ADUS) Surprises With Q4 Sales
Home healthcare provider Addus HomeCare (NASDAQ:ADUS) reported Q4 CY2024 results beating Wall Street’s revenue expectations, with sales up 7.5% year on year to $297.1 million. Its non-GAAP profit of $1.38 per share was 1.6% above analysts’ consensus estimates.
